Covaxx
Hauppauge
About Covaxx
Covaxx has announced that their vaccine development efforts will be consolidated under the newly formed holding company, Vaxxinity, Inc. The company is headquartered in Dallas, Texas, and has operations in Asia, Europe, Latin America, and the United States. Vaxxinity has acquired wholly-owned subsidiaries COVAXX and United Neuroscience. Vaxxinity's Board of Directors has been appointed by Lou Reese, the Executive Chairman of COVAXX. Mei Mei Hu, former CEO of COVAXX, has been named CEO of Vaxxinity.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $32.9M
- Last round: Series Unknown (Aug 2020)
- Website: covaxx.com
- Phone: +1 631-273-2828
Industries & Categories
Biotechnology, Health Diagnostics, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/covaxx-115320 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.